IL124858A - Modified release oral composition comprising bioavailable 5-asa for the treatment of inflammatory bowel diseases - Google Patents

Modified release oral composition comprising bioavailable 5-asa for the treatment of inflammatory bowel diseases

Info

Publication number
IL124858A
IL124858A IL12485896A IL12485896A IL124858A IL 124858 A IL124858 A IL 124858A IL 12485896 A IL12485896 A IL 12485896A IL 12485896 A IL12485896 A IL 12485896A IL 124858 A IL124858 A IL 124858A
Authority
IL
Israel
Prior art keywords
asa
treatment
inflammatory bowel
bowel diseases
bioavailable
Prior art date
Application number
IL12485896A
Other languages
English (en)
Other versions
IL124858A0 (en
Original Assignee
Ferring Farma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL124858(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Farma Lab filed Critical Ferring Farma Lab
Publication of IL124858A0 publication Critical patent/IL124858A0/xx
Publication of IL124858A publication Critical patent/IL124858A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12485896A 1995-12-21 1996-12-23 Modified release oral composition comprising bioavailable 5-asa for the treatment of inflammatory bowel diseases IL124858A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (en) 1995-12-21 1996-12-23 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases

Publications (2)

Publication Number Publication Date
IL124858A0 IL124858A0 (en) 1999-01-26
IL124858A true IL124858A (en) 2003-03-12

Family

ID=24302375

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12485896A IL124858A (en) 1995-12-21 1996-12-23 Modified release oral composition comprising bioavailable 5-asa for the treatment of inflammatory bowel diseases

Country Status (27)

Country Link
EP (1) EP0871434B2 (de)
JP (1) JP4714836B2 (de)
KR (2) KR100542544B1 (de)
CN (1) CN1155369C (de)
AT (1) ATE205704T1 (de)
AU (1) AU702934B2 (de)
BG (1) BG63484B1 (de)
BR (1) BR9612213A (de)
CA (1) CA2240281C (de)
CZ (1) CZ289290B6 (de)
DE (2) DE69615400T3 (de)
DK (1) DK0871434T4 (de)
EE (1) EE03740B1 (de)
ES (1) ES2149733T5 (de)
HU (1) HU228856B1 (de)
IL (1) IL124858A (de)
IS (1) IS1834B (de)
NO (1) NO320498B1 (de)
NZ (1) NZ325201A (de)
PL (1) PL186790B1 (de)
PT (1) PT871434E (de)
RU (1) RU2181043C2 (de)
SI (1) SI0871434T2 (de)
SK (1) SK282669B6 (de)
TR (1) TR199801158T2 (de)
UA (1) UA67721C2 (de)
WO (1) WO1997023199A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
AU764469B2 (en) 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
RU2191782C2 (ru) * 2000-09-21 2002-10-27 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения модифицированной гиалуроновой кислоты
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8282955B2 (en) * 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
PT1441700E (pt) * 2001-10-15 2007-10-29 Ferring Bv Método para a preparação de uma composição compreendendo ácido 5-aminosalicílico para uso em tratamento de colites ulcerosas ou da doença de crohn
RU2286156C2 (ru) * 2001-10-15 2006-10-27 Ферринг Бв Способ приготовления фармацевтической композиции, включающей в себя 5-аминосалициловую кислоту, для применения в лечении неспецифического язвенного колита и болезни крона
JP2007523664A (ja) * 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (de) * 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
ES2690205T3 (es) * 2006-04-13 2018-11-19 Neurotech Pharmaceuticals Co., Ltd. Composición farmacéutica para tratar o prevenir enfermedades inflamatorias
EP2328549B1 (de) * 2008-08-22 2017-11-15 Reckitt Benckiser Healthcare (UK) Limited Zusammensetzungen gegen halsschmerzen
WO2010040113A1 (en) 2008-10-03 2010-04-08 Salix Pharmaceuticals, Ltd. Compositions and methods for the treatment of bowel diseases with granulated mesalamine
EP2340812A1 (de) 2009-12-18 2011-07-06 Ferring International Center S.A. Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (en) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Controlled release formulatin comprising mesalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
FR2649611A1 (fr) * 1989-07-13 1991-01-18 Philippe Perovitch Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
PL186790B1 (pl) 2004-02-27
HU228856B1 (en) 2013-06-28
BG63484B1 (bg) 2002-03-29
DK0871434T4 (da) 2008-04-07
ES2149733T5 (es) 2008-05-01
NO982904D0 (no) 1998-06-22
KR100542544B1 (ko) 2006-05-10
DK0871434T3 (da) 2002-01-07
SI0871434T2 (sl) 2008-04-30
CN1207672A (zh) 1999-02-10
WO1997023199A1 (en) 1997-07-03
KR19990076584A (ko) 1999-10-15
EP0871434B1 (de) 2001-09-19
HK1017615A1 (en) 1999-11-26
EE03740B1 (et) 2002-06-17
IS1834B (is) 2002-11-15
JPH11510191A (ja) 1999-09-07
EP0871434A1 (de) 1998-10-21
SK282669B6 (sk) 2002-11-06
ES2149733T1 (es) 2000-11-16
AU702934B2 (en) 1999-03-11
UA67721C2 (en) 2004-07-15
NO982904L (no) 1998-06-22
BG102556A (en) 1999-02-26
KR20050087886A (ko) 2005-08-31
PL327323A1 (en) 1998-12-07
HUP0001084A2 (hu) 2000-11-28
IS4772A (is) 1998-06-15
DE69615400T2 (de) 2002-05-23
JP4714836B2 (ja) 2011-06-29
KR100598714B1 (ko) 2006-07-10
CA2240281A1 (en) 1997-07-03
HUP0001084A3 (en) 2000-12-28
IL124858A0 (en) 1999-01-26
ATE205704T1 (de) 2001-10-15
EE9800191A (et) 1998-12-15
DE871434T1 (de) 2001-04-05
BR9612213A (pt) 1999-12-28
ES2149733T3 (es) 2002-04-01
DE69615400D1 (de) 2001-10-25
EP0871434B2 (de) 2007-12-12
CN1155369C (zh) 2004-06-30
TR199801158T2 (xx) 1998-09-21
NO320498B1 (no) 2005-12-12
SI0871434T1 (en) 2002-04-30
RU2181043C2 (ru) 2002-04-10
CZ289290B6 (cs) 2001-12-12
SK83498A3 (en) 1999-01-11
CZ194698A3 (cs) 1998-10-14
NZ325201A (en) 1998-11-25
CA2240281C (en) 2007-02-27
DE69615400T3 (de) 2008-08-07
AU1366197A (en) 1997-07-17
PT871434E (pt) 2002-02-28

Similar Documents

Publication Publication Date Title
IL124858A0 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
IL118240A (en) Oral coated capsule dosage form of omega-3 polyunsaturated acid for release of the acid in the intestine
MY104535A (en) Oral composition for the treatment of inflammatory bowel diseases.
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
UA40663C2 (uk) Тверда фармацевтична композиція з регульованим вивільненням лікарського засобу для орального вживання
ZA935650B (en) Pelletised pharmaceutical composition
CA2304948A1 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease
AU2697100A (en) Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
BR0014440A (pt) Formulações de liberação controlada oral

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired